Has the pharmaceutical sector hit bottom this time? Which directions are worth paying attention to?

Since September last year, the pharmaceutical sector has undergone a deep adjustment, with the CSI 300 Pharmaceutical Index retreating over 18%. Recently, the pharmaceutical sector has shown strength against the trend, with some leading companies' stock prices reaching new highs. Analysis indicates that the pharmaceutical sector may have bottomed out, with marginal improvements in valuation and fundamentals. Future investments should focus on the innovative drug field, and although the macro environment remains uncertain in the short term, investment strategies should emphasize structural opportunities